Metabolism and nutrition disorders: hyperglycemia.
Respiratory, thoracic and mediastinal disorders: pharyngolaryngeal pain, epistaxis.
Gastrointestinal disorders: diarrhea, dyspepsia, nausea, flatulence, abdominal discomfort, eructation.
Musculoskeletal and connective tissue disorders: myalgia, joint swelling, muscle fatigue, neck pain.
Psychiatric disorders: nightmare.
Eye disorders: vision blurred.
Ear and labyrinth disorders: tinnitus.
Hepatobiliary disorders: hepatitis, cholestasis.
Skin and subcutaneous tissue disorders: urticaria.
General disorders: malaise, pyrexia.
The following additional undesirable effects have been reported: Blood and lymphatic system disorders: thrombocytopenia.
Immune system disorders: allergic reactions including anaphylaxis.
Injury, poisoning and procedural complications: tendon rupture.
Metabolism and nutrition disorders: weight gain.
Nervous system disorders: hypoesthesia, amnesia, dizziness, dysgeusia.
Gastrointestinal disorders: pancreatitis.
Skin and subcutaneous tissue disorders: Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, erythema multiforme, bullous rashes.
Musculoskeletal and connective tissue disorders: rhabdomyolysis, immune mediated necrotizing myopathy, myositis, back pain.
General disorders: chest pain, peripheral edema, fatique.
Investigations: liver function test abnormal, blood creatine phosphokinase increased, white blood cells urine positive.
View ADR Monitoring Form